Long-Term Assets: The sum of all assets classified as non-current.
Virax Biolabs Group Limited (VRAX) had Long-Term Assets of $1.90M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$6.83M |
|
$1.90M |
|
|
Long-Term Assets |
$1.90M |
$8.32M |
|
$0.69M |
|
-- |
|
-- |
|
$0.99M |
|
$7.33M |
|
$7.33M |
|
$7.33M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.62M |
|
$-0.26M |
|
$7.09M |
|
$4.23M |
|
$6.44M |
|
$2.21M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|